FDA finalises mobile medical applications guidance
On 23 September 2013, the Food and Drug Administration (FDA) released the long-awaited mobile medical applications final guidance. Coming more than two years after its initial draft, the final guidance provides further clarity and insight into the FDA’s current thinking on the regulation of applications meant to run on a mobile platform or on a browser tailored for use on a mobile platform.
Following release of the earlier draft guidance, the FDA solicited public comment and reportedly received more than 130 such comments. According to the agency, the comments were largely supportive of the FDA’s general proposed approach. Consistent with that view, the final guidance proposes the same fundamental approach to regulation of mobile medical apps as was featured in the draft guidance…
If you are registered and logged in to the site, click on the link below to read the rest of the Hogan Lovells briefing. If not, please register or sign in with your details below.
News from Hogan Lovells
News from The Lawyer
Briefings from Hogan Lovells
The UK government supports the European Commission’s decision not to impose mandatory quotas; it favours a self-regulatory national level approach.
Equality between men and women was firmly addressed in Spain by a 2007 act on the effective equality between men and women.
Analysis from The Lawyer
When a firm shouts loudly about a landmark merger, as SJ Berwin did when it joined forces with King & Wood Mallesons, departures are always likely to come under the spotlight.
The Lawyer’s latest Top 50 litigation firms list shows that business for dispute specialists is roaring along while new in-depth detail reveals the winning strategies